Development of meningococcal polysaccharide conjugate vaccine that can elicit long-lasting and strong cellular immune response with hepatitis B core antigen virus-like particles as a novel carrier protein
文献类型：期刊论文
| 作者 | Xu, Lingling1,2; Li, Zhengjun2,3; Su, Zhiguo2; Yang, Yanli2; Ma, Guanghui2; Yu, Rong1; Zhang, Songping2 |
| 刊名 | VACCINE
 |
| 出版日期 | 2019-02-08 |
| 卷号 | 37期号:7页码:956-964 |
| 关键词 | Neisseria meningitidis Conjugate vaccine Hepatitis B core antigen Virus-like particles |
| ISSN号 | 0264-410X |
| DOI | 10.1016/j.vaccine.2018.12.073 |
| 英文摘要 | Neisseria meningitidis caused meningitis is life-threatening acute infection with high fatality and high frequency of severe sequelae. Meningococcal capsular polysaccharides can be used to prevent meningococcal disease; while conjugating the polysaccharides to carrier protein was found necessary to improve the immunogenicity and induce memory responses in infants and young children. Nevertheless, repeated administration of glycoconjugate vaccines might lead to carrier-induced epitope suppression due to limited number of carrier proteins. Here in this study, full-length hepatitis B core antigen virus-like particles (HBc VLPs) was used as a novel potential carrier protein for conjugation of meningococcal group C polysaccharides (CPS) with heterobifunctional polyethylene glycol (PEG) of different length (2, 5 and 10 kDa) as linkers. The physiochemical properties of the CPS-PEG-HBc conjugate vaccines were fully characterized. The TEM, DLS, native agarose gel electrophoresis, and HPLC analyses all confirmed the successful conjugation. As compared to plain CPS and the physical mixture of CPS and HBc, the immunization with the conjugate vaccines can generate about 10 times increase in CPS specific IgG titers with a significant boosting effect. HBc conjugation induced a shift to a Th1 cellular immune type response, as assessed by the increased IgG2a subclass production. In addition, vaccination of the conjugate vaccines elicited much enhanced avidity functional antibody and long-lasting immunological memory. IgG titers elicited by CPS-P2k-HBc, CPS-P5k-HBc and CPS-PlOk-HBc at week 18 maintained 38.1%, 17.9% and 33.3% of their peak values. All these results demonstrated that HBc VLPs can be used as potential carrier protein to develop polysaccharide conjugate vaccines effective in eliciting long-lasting and strong cellular immune response. (C) 2019 Elsevier Ltd. All rights reserved. |
| WOS关键词 | TETANUS TOXOID-CONJUGATE ; QUANTITATIVE ESTIMATION ; IMMUNOGENICITY ; SEQUENCE ; EPITOPE |
| 资助项目 | National Key R & D Program of China[2016YFD0500800] ; National Key R & D Program of China[2016YFD0500809] ; National Natural Sciences Foundation of China[21821005] ; National Natural Sciences Foundation of China[81773623] ; National Natural Sciences Foundation of China[21808226] |
| WOS研究方向 | Immunology ; Research & Experimental Medicine |
| 语种 | 英语 |
| WOS记录号 | WOS:000458342400009 |
| 出版者 | ELSEVIER SCI LTD |
| 资助机构 | National Key R & D Program of China ; National Natural Sciences Foundation of China |
| 源URL | [http://ir.ipe.ac.cn/handle/122111/27945]  |
| 专题 | 中国科学院过程工程研究所 |
| 通讯作者 | Yu, Rong; Zhang, Songping |
| 作者单位 | 1.Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Minist Educ, Chengdu 610041, Sichuan, Peoples R China 2.Chinese Acad Sci, Inst Proc Engn, State Key Lab Biochem Engn, Beijing 100190, Peoples R China 3.Univ Chinese Acad Sci, Beijing 100049, Peoples R China |
| 推荐引用方式 GB/T 7714 | Xu, Lingling,Li, Zhengjun,Su, Zhiguo,et al. Development of meningococcal polysaccharide conjugate vaccine that can elicit long-lasting and strong cellular immune response with hepatitis B core antigen virus-like particles as a novel carrier protein[J]. VACCINE,2019,37(7):956-964. |
| APA | Xu, Lingling.,Li, Zhengjun.,Su, Zhiguo.,Yang, Yanli.,Ma, Guanghui.,...&Zhang, Songping.(2019).Development of meningococcal polysaccharide conjugate vaccine that can elicit long-lasting and strong cellular immune response with hepatitis B core antigen virus-like particles as a novel carrier protein.VACCINE,37(7),956-964. |
| MLA | Xu, Lingling,et al."Development of meningococcal polysaccharide conjugate vaccine that can elicit long-lasting and strong cellular immune response with hepatitis B core antigen virus-like particles as a novel carrier protein".VACCINE 37.7(2019):956-964. |
入库方式： OAI收割
来源：过程工程研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。